SCHEMBL1647423

SCHEMBL1647423

Cc1cc(C)nc(N(CCCN(C)C)c2ccc([N+](=O)[O-])cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.42
HTT P42858 3/20 0.39
ACHE P22303 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ALDH1A1 P00352 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
NPSR1 Q6W5P4 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
PHLPP2 Q6ZVD8 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
POLB P06746 1/20 0.35
JAK2 O60674 1/20 0.35
MITF O75030 1/20 0.35
KMT2A Q03164 1/20 0.35
PAX8 Q06710 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1646716 0.85 MAPT (0.40) MAPTHTTACHEHSD17B10ALDH1A1
SCHEMBL943658 0.83 MAPT (0.57) MAPTHTTACHEHSD17B10ALDH1A1
SCHEMBL943613 0.81 NOS1 (0.43) ACHEPOLBKDM4ENOS3NOS1
SCHEMBL942774 0.80 MAPT (0.52) MAPTHTTACHEHSD17B10ALDH1A1
SCHEMBL1645549 0.77 MAPT (0.46) MAPTHTTL3MBTL1NPSR1TSHR
SCHEMBL942649 0.74 MAPT (0.45) MAPTHTTACHEHSD17B10ALDH1A1
SCHEMBL6941718 0.72 MAPT (0.57) MAPTHTTACHEHSD17B10ALDH1A1
SCHEMBL3158429 0.72 MAPT (0.76) MAPTHTTACHEHSD17B10ALDH1A1
SCHEMBL1993805 0.71 MAPT (0.45) MAPTHTTALDH1A1L3MBTL1MAPK1
SCHEMBL1645594 0.71 KCNH2 (0.51) MAPTHTTALDH1A1KMT2ACHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303329-A1 ANTIFUNGAL COMBINATION THERAPY F2G Limited (GB) 2011-04-06 EP disclosed
WO-2009144473-A1 ANTIFUNGAL COMBINATION THERAPY F2G LIMITED (GB) 2009-12-03 WO disclosed